Literature DB >> 1408490

Candida lusitaniae infection in the newborn: case report and review of the literature.

A M Yinnon1, K A Woodin, K R Powell.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1408490     DOI： 10.1097/00006454-199210000-00014

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  10 in total

1.  Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.

Authors:  Florence Chapeland-Leclerc; Julien Bouchoux; Abdelhak Goumar; Christiane Chastin; Jean Villard; Thierry Noël
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients.

Authors:  F François; T Noël; R Pépin; A Brulfert; C Chastin; A Favel; J Villard
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  Clavispora lusitaniae and Chaetomium atrobrunneum as rare agents of cutaneous infection.

Authors:  Hao Zhang; Yuping Ran; Dongming Li; Yongfang Liu; Yun Xiang; Ruifeng Zhang; Yaling Dai
Journal:  Mycopathologia       Date:  2009-12-18       Impact factor: 2.574

4.  A STE12 homolog is required for mating but dispensable for filamentation in candida lusitaniae.

Authors:  L Y Young; M C Lorenz; J Heitman
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

Review 5.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Usefulness of McRAPD for typing and importance of biofilm production in a case of nosocomial ventriculoperitoneal shunt infection caused by Candida lusitaniae.

Authors:  Petr Hamal; Juraj Hanzen; Frantisek Horn; Jitka Trtkova; Lenka Ruskova; Renata Vecerova; Filip Ruzicka; Anna Vollekova; Vladislav Raclavsky
Journal:  Folia Microbiol (Praha)       Date:  2011-09-06       Impact factor: 2.099

7.  Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.

Authors:  Laura Y Young; Christina M Hull; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis; R N Jones
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Uncommon cause of fungemia in a patient with renal cell cancer: A case report of Candida lusitaniae Fungemia.

Authors:  Rashmi Mishra; Paul Kelly; Omesh Toolsie; Puvanalingam Ayyadurai; Muhammad Adrish
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

10.  Candida lusitaniae in Kuwait: Prevalence, antifungal susceptibility and role in neonatal fungemia.

Authors:  Ziauddin Khan; Suhail Ahmad; Noura Al-Sweih; Seema Khan; Leena Joseph
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.